Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 1/20 | 0.53 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | ACP1 | P24666 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21356428 | 0.77 | PIK3CG (0.37) | PIK3CGPIK3C3ALDH1A1MEN1KMT2A | |
| SCHEMBL9686102 | 0.73 | ALDH1A1 (0.38) | PIK3CGPIK3C3ALDH1A1MEN1KMT2A | |
| SCHEMBL1915 | 0.69 | PIK3CG (0.44) | PIK3CGPIK3C3ALDH1A1ADORA2AADORA1 | |
| SCHEMBL21356495 | 0.64 | BRD4 (0.38) | ALDH1A1ADORA2AADORA1KDM4E | |
| SCHEMBL1992699 | 0.61 | ALDH1A1 (0.43) | PIK3CGPIK3C3ALDH1A1ADORA2AADORA1 | |
| SCHEMBL12332534 | 0.58 | ADORA1 (0.48) | PIK3CGPIK3C3ADORA2AADORA1YTHDC1 | |
| SCHEMBL22509881 | 0.55 | F2RL1 (0.33) | PIK3CGPIK3C3 | |
| SCHEMBL16470899 | 0.54 | ADORA1 (0.47) | PIK3CGPIK3C3ADORA2AADORA1KDM4E | |
| SCHEMBL2414860 | 0.54 | GDA (0.49) | PIK3CGPIK3C3ALDH1A1ADORA2AADORA1 | |
| SCHEMBL4560085 | 0.54 | GDA (0.53) | ALDH1A1MEN1KMT2AADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9739767-B2 | Method of screening for plant defense activators, plant defense activators, and method of enhancing immune response | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9739767-B2 | Method of screening for plant defense activators, plant defense activators, and method of enhancing immune response | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20150141252-A1 | Method of Screening for Plant Defense Activators, Plant Defense Activators, and Method of Enhancing Immune Response | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2015-05-21 | — | — | US | disclosed |
| US-20150141252-A1 | Method of Screening for Plant Defense Activators, Plant Defense Activators, and Method of Enhancing Immune Response | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2015-05-21 | — | — | US | disclosed |
| WO-2014083327-A1 | ADENINE DERIVATIVES SUITABLE FOR THE TREATMENT OF (INTER ALIA) MUSCULAR DYSTROPHY | MD PHARMA AB (SE) | 2014-06-05 | — | — | WO | disclosed |
| WO-2012029539-A1 | METHOD OF SCREENING FOR PLANT DEFENSE ACTIVATORS, PLANT DEFENSE ACTIVATORS, AND METHOD OF ENHANCING IMMUNE RESPONSE | TOKYO UNIVERSITY OF SCIENCE EDUCATIONAL FOUNDATION ADMINISTRATIVE ORGANIZATION (JP) | 2012-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141252-A1 | Method of Screening for Plant Defense Activators, Plant Defense Activators, and Method of Enhancing Immune Response | NFATC1, TRAF6, STING1 | PIK3CG 3416/4885PIK3C3 4030/4885ALDH1A1 4601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.